Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David H Adams, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
45 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Good Samaritan
Phoenix, Arizona, United States
- Kaiser Permanente - Los Angeles Medical Center
Los Angeles, California, United States
- University of Southern California University Hospital
Los Angeles, California, United States
- El Camino Hospital
Mountain View, California, United States
- Va Palo Alto Health Care System
Palo Alto, California, United States
- Hartford Hospital
Hartford, Connecticut, United States
- Yale New Haven Hospital
New Haven, Connecticut, United States
- Washington Hospital Center / Georgetown Hospital
Washington D.C., District of Columbia, United States
- University of Miami Health System / Jackson Memorial Hospital
Miami, Florida, United States
- Mount Sinai Medical Center
Miami Beach, Florida, United States
- Piedmont Heart Institute
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- St. Vincent Heart Center of Indiana
Indianapolis, Indiana, United States
- Iowa Heart Center
Des Moines, Iowa, United States
- University of Kansas Hospital
Kansas City, Kansas, United States
- Cardiovascular Institute of the South/terrebonne General
Houma, Louisiana, United States
- Johns Hopkins Hospital
Baltimore, Maryland, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- University of Michigan Health Systems
Ann Arbor, Michigan, United States
- Detroit Medical Center Cardiovascular Institute
Detroit, Michigan, United States
- St. John Hospital and Medical Center
Detroit, Michigan, United States
- Spectrum Health Hospitals
Grand Rapids, Michigan, United States
- Morristown Memorial Hospital
Morristown, New Jersey, United States
- North Shore University Hospital/ Long Island Jewish Hospital
Manhasset, New York, United States
- Lenox Hill Hospital
New York, New York, United States
- Nyu Langone Medical Center
New York, New York, United States
- the Mount Sinai Medical Center
New York, New York, United States
- St. Francis Hospital
Roslyn, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Wake Forest University - Baptist Medical Center
Winston-Salem, North Carolina, United States
- University Hospitals - Case Medical Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital
Columbus, Ohio, United States
- the Ohio State University Medical Center - the Richard M. Ross Heart Hospital
Columbus, Ohio, United States
- Geisinger Medical Center
Danville, Pennsylvania, United States
- Pinnacle Health
Harrisburg, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor Heart and Vascular Hospital
Dallas, Texas, United States
- Texas Heart Institute at St. Luke'S Episcopal Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Feb 2012
- Primary completion
- 30 Nov 2015
- Completion
- 18 Nov 2019
- Last update posted
- 25 Oct 2022
- Registered enrollment
- 2,777
- Registry id
- NCT01531374
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.